Kepler Capital Keeps Their Hold Rating on Sanofi (SNYNF)
at www.tipranks.com (Fri, 30-Jan 8:50 PM)
Sanofi Earnings Call: Profitable Growth Amid Rising Risks
at www.tipranks.com (Fri, 30-Jan 7:29 PM)
Regeneron Posts Lower Eylea Sales Amid Rising Competition, Plans $2 Billion New Factory
at www.benzinga.com (Fri, 30-Jan 10:56 AM)
Sanofi graft-versus-host disease asset Rezurock gains EU approval recommendation
at seekingalpha.com (Fri, 30-Jan 8:51 AM)
Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds
at seekingalpha.com (Fri, 30-Jan 7:07 AM)
TrumpRx launch now delayed - report
at seekingalpha.com (Thu, 29-Jan 1:53 PM)
Sanofi Posts Strong 2025 Sales and EPS Growth, Sets High-Single-Digit Outlook for 2026
at www.tipranks.com (Thu, 29-Jan 9:41 AM)
Sanofi (SNYNF) Gets a Hold from J.P. Morgan
at www.tipranks.com (Thu, 29-Jan 8:06 AM)
Sanofi: De-Risked Earnings and Robust Medium-Term Growth Overlooked by Discounted Valuation
at www.tipranks.com (Thu, 29-Jan 6:06 AM)
Jefferies Sticks to Their Buy Rating for Sanofi (SNYNF)
at www.tipranks.com (Thu, 29-Jan 4:56 AM)
Sanofi anticipates profitable growth to continue over at least five years
at seekingalpha.com (Thu, 29-Jan 4:09 AM)
Sanofi Non-GAAP EPS of €1.53 beats by €0.06, revenue of €11.3B beats by €170M; issues FY26 outlook
at seekingalpha.com (Thu, 29-Jan 1:34 AM)
Market Chameleon (Mon, 15-Dec 8:16 AM)
Sanofi’s $470M Vigil Neuroscience Deal Underscores 2025’s Record Year for Biotech Innovation
Market Chameleon (Tue, 18-Nov 7:10 AM)
